Close Menu

NEW YORK – DiaSorin Molecular said on Wednesday that it has received additional funding from the US Health and Human Services Biomedical Advanced Research and Development Authority to validate its Simplexa COVID-19 Direct kit and Simplexa COVID-19 & Flu A/B Direct kit.

The funding will also be used to submit the kits to the US Food and Drug Administration for 510(k) clearance. Both tests are for use with DiaSorin's Liaison MDX platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.